Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients

OBJECTIVE: The purpose of this study was to retrospectively assess the pattern, compliance, efficacy and safety of bevacizumab in Chinese ovarian cancer patients. METHODS: We reviewed the clinicopathological data of patients with histologically confirmed epithelial ovarian cancer, fallopian tube can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Nan, Zheng, Hong, Gao, Yunong, Shu, Tong, Wang, Hongguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103494/
https://www.ncbi.nlm.nih.gov/pubmed/37055754
http://dx.doi.org/10.1186/s12905-023-02329-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103494/
https://www.ncbi.nlm.nih.gov/pubmed/37055754
http://dx.doi.org/10.1186/s12905-023-02329-9

Ejemplares similares